Andrew Cooper

Work

Analyst Andrew Cooper works at RAYMOND JAMES and is focused on the Healthcare sector with 250 price targets and ratings documented since 2014 spanning on 13 stocks. Analyst's average stock valuation to be materialised ratio is 36.03% with an average time for price targets to be met of 79.31 days.

Most recent stock forecast was given on NEO, NeoGenomics, Inc at 11-Nov-2022.

Andrew Cooper best performing recommendations are on OSUR (ORASURE TECHNOLOGIES, INC).
The best stock recommendation documented was for VCYT (VERACYTE, INC) at 11/4/2022. The price target of $27 was fulfilled within 6 days with a profit of $2.62 (10.75%) receiving and performance score of 17.91.

Average potential price target upside

CDNA CVET EXAS NEO NVTA OSUR PROG QDEL VCYT AVTR HAE HOLX LMDX
CDNA CVET EXAS NEO NVTA OSUR PROG QDEL VCYT AVTR HAE HOLX LMDX